BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7539154)

  • 1. The biophysics of sickle cell hydroxyurea therapy.
    Eaton WA; Hofrichter J
    Science; 1995 May; 268(5214):1142-3. PubMed ID: 7539154
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease.
    Dover GJ; Charache S
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):61-6. PubMed ID: 1379374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea, sickle cell disease and renal transplantation.
    Allen A; Scoble J; Snowden S; Hambley H; Bellingham A
    Nephron; 1997; 75(1):106-7. PubMed ID: 9031282
    [No Abstract]   [Full Text] [Related]  

  • 4. Stimulation of fetal hemoglobin production by hydroxyurea in sickle cell anemia.
    Dover GJ; Charache S
    Prog Clin Biol Res; 1989; 316B():295-306. PubMed ID: 2482499
    [No Abstract]   [Full Text] [Related]  

  • 5. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
    Rodgers GP
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
    Platt OS; Orkin SH; Dover G; Beardsley GP; Miller B; Nathan DG
    Trans Assoc Am Physicians; 1984; 97():268-74. PubMed ID: 6085528
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract]   [Full Text] [Related]  

  • 8. Sickle cell paths converge on hydroxyurea.
    Platt OS
    Nat Med; 1995 Apr; 1(4):307-8. PubMed ID: 7585059
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of fetal hemoglobin in sickle cell patients by hydroxyurea: the N.I.H. experience.
    Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW
    Prog Clin Biol Res; 1989; 316B():281-93. PubMed ID: 2482498
    [No Abstract]   [Full Text] [Related]  

  • 10. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ; Charache S; Boyer SH
    Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527
    [No Abstract]   [Full Text] [Related]  

  • 11. Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.
    Coleman E; Inusa B
    Clin Pediatr (Phila); 2007 Jun; 46(5):386-91. PubMed ID: 17556734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From Hemoglobin SS to SF: interest of hydroxyurea in the management of sickle cell disease in two Congolese children and review of the literature].
    Nkashama GM; Wakamb GK; Mulangu AM; Nkashama GM; Kupa BK; Numbi OL
    Pan Afr Med J; 2015; 21():124. PubMed ID: 26327961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle cell disease severity: an introduction.
    Pace BS; Goodman SR
    Exp Biol Med (Maywood); 2016 Apr; 241(7):677-8. PubMed ID: 27190296
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathophysiologically based drug treatment of sickle cell disease.
    Steinberg MH
    Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea.
    Rodgers GP; Dover GJ; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1990 Apr; 322(15):1037-45. PubMed ID: 1690857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
    N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of fetal hemoglobin in sickle cell disease.
    Bunn HF
    Blood; 1999 Mar; 93(6):1787-9. PubMed ID: 10068648
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.
    Okam MM; Ebert BL
    Expert Rev Hematol; 2012 Jun; 5(3):303-11. PubMed ID: 22780210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease.
    Atweh GF; Schechter AN
    Curr Opin Hematol; 2001 Mar; 8(2):123-30. PubMed ID: 11224687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickle cell pain & hydroxyurea.
    Day SW; Wynn LW
    Am J Nurs; 2000 Nov; 100(11):34-8; quiz 38-9. PubMed ID: 11103633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.